Nathan Henry Mertens, | |
3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601-4485 | |
(218) 444-8280 | |
(218) 444-8337 |
Full Name | Nathan Henry Mertens |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 4 Years |
Location | 3835 Supreme Ct Nw Ste 2, Bemidji, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548887243 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 11831 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Choice Therapy Pa | 7618022930 | 31 |
News Archive
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham's Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet.
› Verified 9 days ago
Provider Name | Choice Therapy Pa |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1831325620 PECOS PAC ID: 7618022930 Enrollment ID: O20090909000580 |
News Archive
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham's Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Nathan Henry Mertens, 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601-4485 Ph: (218) 444-8280 | Nathan Henry Mertens, 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601-4485 Ph: (218) 444-8280 |
News Archive
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham's Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet.
› Verified 9 days ago
Cody Schepp, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601 Phone: 218-444-8280 | |
Jarad Syrstad, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5899 | |
Andrea Lynn Brodina, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 677 Anne St Nw, Bemidji, MN 56601 Phone: 218-556-9667 | |
Austin Treadwell, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1009 15th St Nw, Bemidji, MN 56601 Phone: 901-626-8996 | |
Jordan B Peterson, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601 Phone: 218-444-8280 Fax: 218-444-8337 | |
Daltin Schmitz, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601 Phone: 218-441-5232 | |
Benjamin Holter, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3835 Supreme Ct Nw Ste 2, Bemidji, MN 56601 Phone: 218-444-8280 Fax: 218-444-8337 |